Scientists discover how pancreatic cancer rewrites its DNA to evade treatment and block a key gene in the lab.

What it means

Scientists have discovered that pancreatic cancer cells continuously reshape their DNA—through a process involving genetic plasticity and clonal evolution—to become more aggressive and evade treatment. In laboratory experiments, researchers identified and blocked a key gene that enables this DNA rewriting, effectively stopping the cancer's ability to adapt and opening a potential new therapeutic target.

Accuracy & sourcesGrounded

The claim is based on a peer-reviewed study (likely published in a journal such as Nature or Cell) analyzing single-cell genetic activity from 443,451 cells across 62 pancreatic tumors. It is reported by Science Daily, a reputable secondary source, and corroborated by multiple other science news outlets. The evidence is strong but remains preclinical, as blocking the gene has only been tested in lab experiments.

How new

This finding is genuinely new, based on a study reported on October 25, 2026, with no indication of prior recirculation.

Go deeper